Achieve Life Sciences, Inc. ACHV
7.54
(0.29)
(3.70%)
as of 25 Sep
- Market cap
- $814.0M
- P/E
- 0.0×
Follow ACHV
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | — | — | — | — | — | — | — | — |
P/S ratio |
0.01 | — | — | — | — | — | — | — | — | — |
P/FCF ratio |
0.00 | — | — | — | — | — | — | — | — | — |
P/Operating CF |
(1.81) | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.18 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | — | — | — | — | — | — | — | — | — |
EV/Sales |
0.06 | — | — | — | — | — | — | — | — | — |
EV/EBITDA |
0.28 | — | — | — | — | — | — | — | — | — |
EV/Operating CF |
(4.92) | — | — | — | — | — | — | — | — | — |
EV/FCF |
(1.85) | — | — | — | — | — | — | — | — | — |
Quick Ratio |
0.17 | 2.74 | 4.47 | 5.81 | 12.22 | 9.49 | 1.15 | 0.75 | 5.14 | 4.01 |
Current Ratio |
0.01 | 2.93 | 4.75 | 6.04 | 12.60 | 9.80 | 1.27 | 0.82 | 5.46 | 4.39 |
Net Debt/EBITDA |
(0.55) | 0.86 | 1.16 | 1.00 | 2.46 | 0.85 | 0.21 | (0.04) | 0.63 | 0.36 |
Debt/Assets |
21.78% | 0.27% | 0.12% | 1.72% | 0.42% | 31.55% | 54.05% | 86.37% | 25.78% | 39.51% |
Debt/Equity |
1.36 | 0.00 | 0.00 | 0.02 | 0.00 | 0.53 | 1.95 | (11.55) | 0.48 | 0.77 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.16 | 0.86 | 0.84 | 0.93 | 0.91 | 0.89 | 0.89 | 0.82 | 0.75 | 0.91 |
Capex/Depreciation |
0.00 | 0.00 | (0.13) | (0.21) | (0.07) | 0.00 | 0.00 | (0.09) | 0.00 | (0.01) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (6.49%) | (249.33%) | (107.15%) | (96.86%) | (53.24%) | (101.49%) | (233.04%) | (869.88%) | (409.51%) | (257.67%) | |
| (3.98%) | (154.51%) | (87.57%) | (81.64%) | (48.00%) | (75.51%) | (109.31%) | (120.85%) | (137.33%) | (135.90%) | |
ROIC |
(75.23%) | (172.71%) | (655.87%) | (590.96%) | (575.45%) | (159,105.77%) | 0.00% | 0.00% | 0.00% | (2,109.47%) |
Return on Tangible Assets |
44.12% | (267.65%) | (103.13%) | (112.90%) | (43.03%) | (82.63%) | (722.94%) | 778.26% | (133.71%) | (177.39%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
1.00 | 0.36 | 0.18 | 0.15 | 0.07 | 0.06 | 0.08 | 0.12 | 0.05 | 0.04 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(28.33) | — | — | — | — | — | — | — | — | — |
Graham Number |
0.00 | — | — | — | — | — | — | — | — | — |
Earnings Yield |
(330.91%) | — | — | — | — | — | — | — | — | — |
Free Cash Flow Yield |
(479.50%) | — | — | — | — | — | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2,020.00) | (379.46) | (60.53) | (36.93) | (4.96) | (3.63) | (3.55) | (1.23) | (0.93) | (1.13) |
Capex per Share |
0.00 | 0.00 | (0.21) | (0.13) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(2,020.00) | (379.46) | (60.73) | (37.06) | (4.96) | (3.63) | (3.55) | (1.24) | (0.93) | (1.13) |
Cash per Share |
150.00 | 229.42 | 83.21 | 40.45 | 13.19 | 5.30 | 2.34 | 0.78 | 1.07 | 0.84 |
Shareholders Equity per Share |
6,100.00 | 328.29 | 90.04 | 43.81 | 13.71 | 3.45 | 0.78 | (0.07) | 0.65 | 0.49 |
Interest Debt per Share |
0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6,100.00 | 328.29 | 90.04 | 43.81 | 13.71 | 3.45 | 0.78 | (0.07) | 0.65 | 0.49 |
Free Cash Flow |
(0.20) | (9.11) | (10.66) | (15.27) | (13.49) | (29.44) | (37.57) | (24.50) | (29.77) | (49.47) |
Working Capital |
(3.05) | 3.90 | 12.27 | 14.47 | 34.04 | 40.04 | 5.73 | (3.83) | 29.79 | 30.81 |
Capital Expenditures |
(0.05) | — | (0.04) | (0.05) | (0.02) | — | — | (0.02) | — | 0.00 |
Net Current Asset Value |
(3.18) | 3.90 | 12.26 | 14.31 | 33.96 | 25.12 | 5.66 | (3.84) | 18.73 | 19.62 |
EV/EBIT |
0.00 | — | — | — | — | — | — | — | — | — |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 | — | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
0.03 | — | — | — | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.86 | 4.78 | 8.06 | 4.46 | 1.36 | 3.16 | 1.86 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(31.64%) | (68.34%) | (35.03%) | (43.54%) | (18.64%) | (34.30%) | (76.51%) | (79.40%) | (45.65%) | (66.45%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.32 | 0.26 | 0.01 | 0.01 | — | 0.08 | 0.13 | 0.11 | — | — |
Average Payables |
0.72 | 0.15 | 0.18 | 0.50 | 0.60 | 0.59 | 1.25 | 1.14 | 1.28 | 1.41 |
Average Assets |
31.01 | 6.85 | 14.49 | 20.08 | 30.69 | 43.91 | 38.74 | 24.67 | 29.00 | 40.21 |
Average Common Equity |
19.03 | 4.24 | 11.84 | 16.93 | 27.67 | 32.66 | 18.17 | 3.43 | 9.73 | 21.21 |
Columns are period end dates